NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8850
+0.0150 (1.72%)
Jan 30, 2026, 4:00 PM EST - Market closed
NMTC Revenue
In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth. NeuroOne Medical Technologies had revenue of $2.74M in the quarter ending September 30, 2025, with 906.64% growth.
Revenue (ttm)
$12.10M
Revenue Growth
+250.35%
P/S Ratio
2.94
Revenue / Employee
$672,094
Employees
18
Market Cap
44.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Sep 30, 2018 | - | - | - |
| Jun 30, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Sep 30, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Sep 30, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Sep 30, 2015 | -113.00 | -886.00 | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| Baird Medical Investment Holdings | 31.86M |
| electroCore | 29.84M |
| Spectral AI | 23.17M |
| Elutia | 21.75M |
| IceCure Medical | 2.98M |
NMTC News
- 6 weeks ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - NeuroOne Medical Technologies Corporation - Special Call - Seeking Alpha
- 5 months ago - NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 - GlobeNewsWire
- 5 months ago - NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire
- 6 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% - GlobeNewsWire
- 6 months ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update - GlobeNewsWire
- 6 months ago - NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - GlobeNewsWire